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A DNA fragment coding for the E. coli phoA signal peptide was synthesized and inserted into the expression 
vector pKK223-3. A single Hind111 restriction site is located just at the end of the signal sequence. A gene 
coding for the proteinase inhibitor hirudin, which has previously been synthesized, was inserted into this 
Hind111 site. The hybrid protein was expressed under control of the tat-promoter and secreted into the pe- 
riplasm of E. coli. From the periplasmic fraction two processed proteins were isolated. One of these was 
identical with desulfatohirudin and also had similar biological properties. 
Hirudin Thrombin-speciJic nhibitor (Leech, Hirudo medicinalis) Gene expression 
Alkaline phosphatase Signal sequence Desulfatohirudin 
1. INTRODUCTION 
Hirudin, the proteinase inhibitor protein origin- 
ating from the salivary glands of the leech, Hirudo 
medicinalis, consists of a single polypeptide chain 
composed of 65 amino acid residues [ 1,2]. It is the 
most potent thrombin-specific inhibitor so far 
known. It forms tight complexes with thrombin, 
which exhibit equilibrium dissociation constants as 
low as 4 x lo-” M. The potency and specificity of 
hirudin stimulated interest in its possible use as an 
antithrombotic drug in clinical studies [3]. 
Besides this pharmacological interest, hirudin- 
thrombin complexes may function as an excellent 
model to study protein-protein recognition. For 
this reason novel hirudin molecules with distinct 
biological activities should be generated. We have 
therefore considered the use of recombinant DNA 
for the production of hirudin and hirudin mutants 
derived by oligonucleotide directed site specific 
mutagenesis. A prerequisite for these studies is the 
expression of biologically active hirudin. 
Abbreviation: IPTG, isopropyl-,&D-thiogalactopyrano- 
side 
However, in recent years the expression of 
foreign genes in Escherichia coli and production of 
biologically active products have proven to be dif- 
ficult, especially for polypeptides [4,5]. This was 
also shown for hirudin expression in previously 
published data. Only a small amount of the in- 
hibitor was found in the cytoplasm [6,7]. Therefore 
protein folding, disulfide bonding and protection 
against proteolytic degradation have to be guaran- 
teed. This should be accomplished by co-trans- 
lational transport of the nascent polypeptide chain 
through the cytoplasmic membrane using bacterial 
or eukaryotic signal sequences [8,9]. One of the 
periplasmic proteins of E. coli is the alkaline phos- 
phatase (phoA) which carries in its precursor form 
a signal sequence of 21 amino acids [lo]. Making 
use of this signal sequence we here present he ex- 
pression and processing of hirudin into the peri- 
plasm of E. coli. 
2. MATERIALS AND METHODS 
Deoxyoligonucleotides SPl and SP2 were syn- 
thesized manually on a solid silica gel support, 
deoxyoligonucleotides SP3 and SP4 were assem- 
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the expression vector pKK223-3 (fig.2A). The vec- 
tor carries the tat-promoter and a Shine-Dalgarno 
sequence upstream of the cloning site and addi- 
tionally ribosomal RNA transcription terminators 
(rrnB) downstream of this site. The EcoRI site was 
not reconstituted by the ligation procedure. A 229 
bp DNA fragment coding for hirudin was derived 
from the vector pHIR1 [6] and ligated into the 
Hind111 site of pKK223-3 carrying the phoA signal 
sequence. The vector pHIR21 showed the correct 
orientation of the hirudin gene fragment, as could 
be verified by restriction enzyme analysis with 
WI. pHIR21 directed a tat-promoter controlled 
synthesis of a fusion protein starting with the 
phoA signal peptide at the N-terminus and fol- 
lowed by hirudin (fig.2B). 
Expression of the phoA signal peptide-hirudin 
fusion protein was induced in E. cofi BMH71-18 
harbouring the plasmid pHIR21 by bringing the 
cultures to 0.5 mM IPTG. Time course of the 
hirudin expression was followed by a thrombin in- 
hibitory assay (fig.3). In the stationary phase (21 h 
after induction) hirudin activity reached a level of 
about 350 mIU/l A578 unit cells in total cell ex- 
tracts and periplasmic fractions. An appreciable 
amount of approx. 100 mIU/l A578 unit cells was 
also found in culture supernatants. These hirudin 
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Fig.3. Thrombin inhibitory activity determinations of E. 
coli BMH71-181pHIR21 after induction of gene expres- 
sion by IPTG. (M) Growth curve. Thrombin in- 
hibiting activities in: (M) cell extracts, (a) 
periplasmic fractions and (H) culture supematants 
are given. were 8.4 and 19.5 min, respectively. 
Fig.4. HPLC separation of thrombin inhibitory activity 
containing fractions derived from ion-exchange chroma- 
tography. Chromatographic conditions: column, 
Beckman ODS (0.46 x25 cm); solvent A, 0.1% trifluo- 
roacetic acid in water (v/v); solvent B, 0.1% trifluo- 
roacetic acid in acetonitrile (v/v) mixed with solvent A 
in a ratio of 3 :2 (v/v); flow, 1 ml/min; detector, 1.0 
AUFS at 214 nm; temperature, 25°C; gradient, as in- 
dicated by dashed line. The retention times of I and II 
levels were stable for another 10 h. The results ob- 
tained for hirudin from cell extracts and periplasm 
indicate that nearly all of the thrombin inhibitor 
was secreted into the periplasm. Secretion of 
hirudin into culture supernatants, however, is not 
yet understood. 
350 mIU/I A578 unit cells were observed in the 
periplasmic fraction of E. coli BMH71-lWpHIR21 
24 h after induction of gene expression. Proteins 
and peptides of this fraction were separated by ion- 
exchange chromatography on DEAE-Sephadex 
A-25 followed by HPLC (fig.4). This chromato- 
graphy resulted in two protein peaks (I and II) 
which were analysed by amino acid sequence and 
thrombin inhibitory activity determinations. The 
data from sequencing studies confirmed the pri- 
mary structure of proteins I and II (fig.5). Protein 
II indicates that the signal peptide was correctly 
processed by the leader peptidase at positions 
Alae4- Serm3 during secretion into the periplasm. 
Surprisingly, peptide I showed the same amino 
acid sequence as determined for hirudin [2] except 
375 
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Fig.5. Schematic structure of the phoA signal peptide- 
hirudin fusion and processed hirudin forms from peri- 
plasmic fractions. The primary structures of protein 
peaks I and II isolated as in fig.4 were confirmed by 
amino acid sequence analyses. The first amino acid of 
mature hirudin is numbered + 1. 
that it is missing a sulfated tyrosine residue in posi- 
tion 63. This amino acid was identified as a 
tyrosine by C-terminal sequence analysis with car- 
boxypeptidase Y (cf. (21). The specific activity of 
protein I (desulfatohirudin) was determined as 
550-570 IU/mg and is therefore comparable to 
530-560 IU/mg for desulfatohirudin obtained by 
arylsulfatase treatment of native hirudin from 
leeches [18]. Thrombin inhibitory activity of pro- 
tein II was 500-fold less than that for desulfato- 
hirudin and therefore negligible under assay condi- 
tions. A recalculation of the data obtained for the 
specific activity of desulfatohirudin (protein II) 
and total thrombin inhibitory activity in periplas- 
mic fractions 24 h after induction yielded 4 mg 
desulfatohirudin/l in E. coli BMH7 1- lS/pHIR2 1 
cultures. 
4. DISCUSSION 
Prior usage of the phoA system is documented 
in current patenting literature (Eur. Pat. Appl. EP 
133,321). Using this system we have obtained 25- 
and 3500-times more hirudin activity than in prior 
reports (cf [6] and 171, respectively). As hirudin is 
a secretory protein from the salivary glands of the 
leech the expression of the synthetic gene fused to 
a leader sequence may mimic segregation under 
natural conditions. This indication is supported by 
the sequence of a cDNA clone of a naturally 
occurring hirudin form which presumably is 
translated as a precursor [7]. The amino acid se- 
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quence analyses of the hirudin forms I and II from 
the periplasm demonstrate that the precursor pro- 
tein is exported across the cytoplasmic membrane 
via the signal peptide dependent process. Process 
of the gene product by a leader peptidase to 
hirudin form II took place as expected, whereas 
the origin of form I is still inexplicable. Thrombin 
inhibitory activity measured in the culture super- 
natants was also unexpected. Penetration of 
hirudin across the outer membrane may be due to 
its small molecular size and/or its hydrophilic 
nature [19]. The possibility that hirudin is set free 
by cell lysis is excluded by the data shown in fig.3 
(hirudin can already be detected in supernatants 3
h after induction when cells are still in logarithmic 
growth). 
Hirudin obtained from E. coli does not carry a 
sulfated tyrosine residue in position 63 as was 
shown for hirudin from leeches. This however is 
not a drawback as the removal of the sulfate group 
from hirudin molecules has only a very weak in- 
fluence on the inhibition strength [20]. To obtain 
the sulfatohirudin an effort may be made in a 
eukaryotic expression system, but its success is 
doubtful as the specificity of arylsulfotransferases 
is not yet understood. 
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